Safety Monitoring

Establishment of detection method for related substances of propranolol hydrochloride and study of an unknown impurity β-isomer*

Expand
  • Beijing Institute for Drug Control,NMPA Key Laboratory for Research and Evaluation of Generic Drugs, Beijing Key Laboratory of Analysis and Evaluation on Chinese Medicine,Beijing 102206,China

Received date: 2020-12-02

  Online published: 2024-07-15

Abstract

Objective: To establish a new high performance liquid chromatography method for the determination of related substances of propranolol hydrochloride,to improve the related substance detection method in the quality standard of propranolol hydrochloride in the 2020 edition of the“ Chinese Pharmacopoeia” (Part Two),and to evaluate drug quality. Methods: A new alkaline chromatography column system was used instead of the mixed ion pair method. CERI L-column3 C18(250 mm×4.6 mm,5 μm) was chosen. The buffer pH and organic phase were optimized and 230 nm wavelength which was more sensitive than that of previous method was used. The new method was validated and used to analyze the impurities and determine the structure of the unknown impurities. Results: This method could not only effectively separate the three known impurities (impurity A,B and C),but also solve the overlapping problem of the α-naphthol peak and propranolol peak in the pharmacopoeia methods. A large unknown impurity found in some samples was confirmed with comprehensive structure and synthesis process analysis. This substance was determined to be the isomer of propranolol hydrochloride (named β-isoform). It was synthetic by-products produced by β-naphthol within the synthetic substrate of propranolol hydrochloride -α-naphthol. This β-isoform could not be detected by the methods currently used in pharmacopoeias from various countries. Conclusion: The improved method is sensitive,specific, simple and accurate. It can effectively investigate the composition and content of related substances of propranolol hydrochloride. It provides data reference for the revision of its quality standards.

Cite this article

ZHANG Shu-dong, WU Ke-chun, ZHANG Zhi-jun, WU Zhao-wei, WANG Lin, SUN Yi, ZHANG Zhe, HU Qin . Establishment of detection method for related substances of propranolol hydrochloride and study of an unknown impurity β-isomer*[J]. Chinese Journal of Pharmaceutical Analysis, 2021 , 41(9) : 1519 -1533 . DOI: 10.16155/j.0254-1793.2021.09.05

References

[1] GRECO A,D'ERME AM,GALLARATI BZ,et al. A further experience of propranolol for severe infantile hemangiomas of the face:an observational study[J]. Dermatol Ther,2014,27(4):198
[2] LEE SJ,LEE SB,CHUNG H Y,et al.Current drug therapies for infantile hemangioma:focused on beta blocker[J]. J Korean Med Assoc,2011,54(8):876
[3] CHOBANIAN AV,BAKRIS GL,BLACK HR,et al.The seventh report of the Joint National Committee on prevention,detection, evaluation,and treatment of high blood pressure-The JNC 7 report[J]. JAMA,2003,289(19):2560
[4] MARSCIANI A,PERICOLI R,ALAGGIO R,et al.Massive response of severe infantile hepatic hemangioma to propranolol[J]. Pediatr Blood Cancer,2010,54(1):176
[5] 宁丽. 醋酸奥曲肽联合盐酸普萘洛尔在消化道出血中的疗效及对生活质量的影响[J]. 中国医药指南,2019,17(1):104
NING L.Efficacy of octreotide acetate combined with propranolol hydrochloride in the treatment of gastrointestinal bleeding and its effect on quality of life[J]. Guide China Med,2019,17(1):104
[6] 中华人民共和国药典 2015 年版.华人民共和国药典 2015 年版.二部[S]. 2015:792
ChP 2015. Vol IIhP 2015. Vol II[S]. 2015:792
[7] EP 10.0P 10.0[S]. 2020:3658
[8] BP 020[S]. 2020:735,1182
[9] USP43-NF38[S]. 2020:3717
[10] JP 17[S]. P 17[S]. 2011:1478
[11] GGTG-2017-10860 总局关于发布仿制药参比制剂目录(第五批) 的通告(2017年第89号)[S/0L]. (2017-06-08)[2021-08-02]. https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20170609142901574. html
GCTC-2017-10860 Announcement of the Administration on Issuing the Catalogue of Reference Preparations for Generic Drugs (Fifth batch)(No. 89,2017)[S/OL]. (2017-06-08)[2021-08-02] . https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20170609142901574.html
[12] 杜增辉,高柳娣,张西茹,等. HPLC 法测定咖普苯片中咖啡因、盐酸普萘洛尔、苯妥英钠3 组分的含量[J]. 药物分析杂志, 2001,21(4):279
DU ZH,GAO LD,ZHANG XR,et al.HPLC determination of caffeine,propranolol hydrochloride,phenytoin sodium in Kapuben tablet[J]. Chin J Pharm Anal,2001,21(4):279.
[13] 李晓霞,李延清,王静,等. 盐酸普萘洛尔在碳纳米管修饰玻碳电极上的电化学行为及其应用[J]. 药物分析杂志,2010,30(2):320
LI XX,LI YQ,WANG J,et al.Electrochemical behavior of propranolol hydrochloride at carbon nanotubes modified glassy carbon electrodes and its application[J]. Chin J Pharm Anal, 2010,30(2):320
[14] 冯翠娟,李莉,张春玲,等. 光纤传感技术对盐酸普萘洛尔片快速分析方法学建立[J]. 药物分析杂志,2012,32(4):701
FENG CJ,LI L,ZHANG CL,et al.Establishment of rapid fiber optic sensor analysis method about propranolol hydrochloride tables[J]. Chin J Pharm Anal,2012,32(4):701
[15] 宋辉,高捷,张楠,等. 双离子对试剂在高效液相色谱法测定盐酸普萘洛尔中的作用[J]. 中南药学,2018,16(4):530
SONG H,GAO J,ZHANG N,et al.Role of double ion-pairing agents in determiation of propranolol hydrochloride by HPLC[J]. Cent South Pharm,2018,16(4):530
[16] 郑风敏,王繁华,李彬. 反相高效液相色谱法测定盐酸普萘洛尔片中盐酸普萘洛尔的含量[J]. 天津药学,2021,33(1):9
ZHENG FM,WANG FH,LI B.RP-HPLC determination of propranolol hydrochloride in propranolol hydrochloride tablets[J]. Tianjin Pharm,2021,33(1):9
[17] SUDO Y,WADA T.Characteristics of octadecylsilylated silica gels end-capped by high-temperature silylation[J]. J Chromatogr A, 1998,813(2):239
[18] SUDO Y.Optimization of end-capping of octadecyl-silylated silica gels by high-temperature silylation[J]. J Chromatogr A,1997,757(1-2):21
Outlines

/